Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

novartis_outside_1

Novartis’ sickle cell drug reduces vaso-occlusive crises by 35% at Phase 2

October 10, 2018
Research and Development Novartis, crizanlizumab, pharma, sickle cell disease

Novartis has presented new Phase 2 data for its humanised anti-P-selectin monoclonal antibody crizanlizumab in the treatment of sickle cell …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Jannsen, NHS, Novartis, Novo Nordisk, dementia, top 10

As September came to a close and October began the UK was hit hard in the headlines after American firm …

News

Novartis forge deal with Boston Pharmaceuticals in effort against AMR

October 3, 2018
Research and Development AMR, Antibiotics, Boston Pharmaceuticals, Novartis, US

Swiss multinational Novartis have entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel …

News
acute_lymphoblastic_leukaemia_smear

20 year old man died after leukaemia cell was accidently mixed into CAR T therapy

October 2, 2018
Manufacturing and Production CAR T, CAR-T, Cancer, Kymriah, Novartis, leukaemia, oncology

A 20 year old man died after a single leukaemia cell accidentally ended up in a batch of cells that …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, NHS, Novartis, pharma

Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …

News
novartis_window

Novartis strike $40m deal with Chinese firm Cellular Biomedicine

September 28, 2018
Medical Communications CAR T, CAR-T, China, Kymriah, Novartis, cellular biomedicine, prc

Swiss multinational Novartis have paired up with Chinese drugmaker Cellular Biomedicine (CBMG) in order to manufacture CAR-T therapy Kymriah in …

News
shutterstock_273326141

Novartis joins forces with GARDP for better, accessible infectious disease treatments in the developing world

September 27, 2018
Research and Development, Sales and Marketing GARDP, Novartis, infectious disease, pharma

Novartis has partnered up with the Global Antibiotic Research & Development Partnership (GARDP) to push for faster development and wider …

News
novartis_outside_1

Novartis cuts more than 2500 jobs in Switzerland and the UK

September 25, 2018
Manufacturing and Production Basel, Jobs, Novartis, Switzerland, grimsby, manufacturing

Swiss multinational Novartis are set to cut thousands of jobs across Europe in an effort to boost profitability. The move …

News

Courts back NHS in fight against Novartis and Bayer

September 24, 2018
Sales and Marketing Bayer, Eylea, NHS, Novartis, avastin, ludentis

The NHS has won a court case against multinational pharmaceutical firms Novartis and Bayer, after the companies sought to block …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 21, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Novartis, Novo Nordisk, Senate, UCB, manufacturing, opioid crisis, top 10

Manufacturing took a hit this week as Novo Nordisk announced the loss of 400 jobs while Novartis made the move …

News
kymriah

NICE rejects CAR-T therapy Kymriah for DLBCL in adults

September 19, 2018
Research and Development CAR T, CAR-T, Kymriah, NICE, Novartis, leukaemia

The National Institute for health and Care Excellence (NICE) has rejected Novartis’ CAR-T therapy Kymriah for use in adults with …

News

Novartis to relocate Arnhem operations to Amsterdam, 400 jobs affected

September 19, 2018
Manufacturing and Production, Research and Development Netherlands, Novartis, amsterdam, pahrma, pharma

Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, …

News

NICE recommends Novartis combo as first-ever BRAF-targeted therapy for advanced post-surgery melanoma

September 17, 2018
Sales and Marketing Cancer, NICE, Novartis, Tafinlar, mekinist, melanoma, pharma

NICE has taken the decision to recommend the first ever first BRAF-targeted therapy for use on the NHS in England …

News
hurricane_florence_credit_nasa

Pfizer, Novartis, MSD, Novo and GSK halt operations in wake of Hurricane Florence

September 14, 2018
Medical Communications GSK, Hurricane Florence, MSD, Novartis, Novo Nordisk, Pfizer, pharma

As Hurricane Florence begins to breach the Southeast Coast, major pharma firms have announced they are enacting contingency plans, including …

News
novartis_outside_1

Novartis doubles down on Cosentyx’s efficacy in psoriasis with extensive real-world data

September 13, 2018
Research and Development Cosentyx, Novartis, pharma, psoriasis

Novartis was yet another company to reveal new data on a psoriasis drug at the European Academy of Dermatology and …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025